Zhang, Hao
Bristol-Myers Squibb (United States)
3 papers on CoChatORCID 0000-0002-2926-737X
Most cited papers
- Verified
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA 1 ) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
Cheng, P. T. W., Kaltenbach, R. F., Zhang, H., Shi, J., Tao, S., Li, J., Kennedy, L. J., Walker, S. J., Shi, Y., Wang, Y., et al. (2021) · Journal of Medicinal Chemistry
Sphingolipid Metabolism and SignalingInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Cited by 61
- Verified
Deep Learning for the Classification of Small (≤2 cm) Pulmonary Nodules on CT Imaging: A Preliminary Study
Chae, K. J., Jin, G. Y., Ko, S. B., Wang, Y., Zhang, H., Choi, E. J., & Choi, H. (2020) · Academic Radiology
AI in cancer detectionLung Cancer Diagnosis and Treatment
Cited by 40
- Verified
Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4- and HDAC5-mediated metabolic reprogramming
Feng, S., Zhang, L., Liu, X., Li, G., Zhang, B., Wang, Z., Zhang, H., & Ma, H. (2020) · Journal of Cellular and Molecular Medicine
Metabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free